PharmaMar is a global oncology company headquartered in Spain. From its inception, the Company has set the goal of growing in excellence, size and reach. This process of international growth is still ongoing with now five affiliates across Europe and a hub in the US. We will continue to expand our teams in different regions so we can better address the needs of our stakeholders in every country
.
Oncology Pipeline
PharmaMar develops and commercializes YONDELIS® in Europe and has three clinical-stage programs under development, in addition to trabectedin, for several types of solid and hematological cancers, PM1183, plitidepsin, and PM60184.
Our internationalization aims to put our marine-inspired medical advances within every patient’s reach.
...
